Opinion: The Double Cause Hypothesis may explain environmental factors' effects associating with type 1 diabetes

Keywords

Abstract

References

1. [1]1. Arieli R. Nanobubbles form at active hydrophobic spots on the luminal aspect of blood vessels: consequences for decompression illness in diving and possible implications for autoimmune disease-an overview. Front Physiol 2017;8:591.
2. [2]2. Kaczerska D, Siermontowski P, Olszański R, Krefft K, Małgorzewicz S, Van Damme-Ostapowicz K. The influence of high-fat diets on the occurrence of decompression stress after air dives. Undersea Hyperb Med 2013;40:487‒97.
3. [3]3. Arieli R. Fatty diet, active hydrophobic spots, and decompression sickness. Letter to the Editor. Diving Hyperb Med 2018;48:197
4. [4]4. Arieli R. Was the appearance of surfactants in air breathing vertebrates ultimately the cause of decompression sickness and autoimmune disease? Respir Physiol Neurobiol 2015;206:15-18.
5. [5]5. Aburomi N, Khatib S, Piran R, Arieli R. The double cause hypothesis for autoimmune diseases is Supported in Diabetic Mice (NOD). Medical Res Arch 2023;11:12
6. [6]6. Arieli R., Khatib S., Khatib A., Bukovetzky E., Gottfried O.D. Is the probable spillage of the lung surfactant dipalmitoylphosphatidylcholine the ultimate source of diabetes type1? Respir Physiol Neurobiol 2020;286:103615.
7. [7]7. Arieli R, Khatib S, Tarabeh A, Bakry D, Bukovetzky E, Gottfried OD Testing the Double Cause Hypothesis for autoimmune diseases, dipalmitoylphosphatidylcholine should be measured in plasma or blood vessels of diabetes Type 1? Medical Res Arch 2023;11:4.
8. [8]8. Isaacs SR, Roy A, Dance B, Ward EJ, Foskett DB, Maxwell AJ, Rawlinson WD, Kim KW, Craig ME. Enteroviruses and risk of islet autoimmunity or type 1 diabetes: systematic review and meta-analysis of controlled observational studies detecting viral nucleic acids and proteins. Lancet Diabetes Endocrinol 2023;8:578-592.
9. [9]9. Lloyd RE, Tamhankar M, Lernmark A Enteroviruses and type 1 diabetes: multiple mechanisms and factors? Annu Rev Med 2022;73: 483–499.
10. [10]10. Wang K, Ye F, Chen Y, Xu J, Zhao Y, Wang Y, Lan T. Association between enterovirus infection and type 1 diabetes risk: a meta-analysis of 38 case-control studies. Front Endocrinol 2021;12:706964.
11. [11] 11. Borchers AT, Uibo R, Gershwin ME . The geoepidemiology of type 1 diabetes. Autoimmun Rev 2010;5:A355-365.
12. [12]12. Ogrotis I, Koufakis T, Kotsa K. Changes in the global epidemiology of type 1 diabetes in an evolving landscape of environmental factors: causes, challenges, and opportunities. Medicina 2023;59:668.
13. [13]13. Qick M, Christtiansen J, Bryner J. The growing global burden. Sci Am 2025;333(4): s10-s11.
14. [14]14. Sidahmed S, Geyer S, Beller J. Socioeconomic inequalities in diabetes prevalence in Europe. SAGE Open 2025;15: 1–14.
15. [15]15. Vergès B. Lipid disorders in type 1 diabetes. Diabetes Metab 2009 ;35(5):353-60.
16. [16]16. Oki JC. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy. Pharmacotherapy1995;15(3):317-337.
17. [17]17. Taddei C, Zhou B, Bixby H, Carrillo-Larco RM, et al. NCD risk factor collaboration (NCD-RisC). Repositioning of the global epicentre of non-optimal cholesterol. Nature 2020;582:73–77.
18. [18]18. Lara M, Amigo H. Association between education and blood lipid levels as income increases over a decade: a cohort study. BMC Public Health 2018;18:286.

Authors (1)